Skip to content
industrywatch24

IndustryWatch24

  • About Us
  • Business
  • Healthcare
  • Technology
  • Chemicals
  • Environment
  • Contact Us

Tag: Pfizer

Pfizer Applies for US FDA Approval for Omicron-Adapted Vaccine Booster in Under 5 Kids

December 6, 2022Sandy B

Pfizer and BioNTech has submitted an application to the US Food and Drug Administration (FDA) for emergency use authorization of the Omicron-adapted COVID-19 vaccine booster for children under 5 years. If the vaccine is authorized, the children would receive the primary series of the vaccine consisting of two doses of the original COVID-19 vaccine developed […]

Continue Reading

Pfizer Drops Cardiology Drug after Phase 3 Trials Failed

August 8, 2022August 8, 2022Sandy B

Pfizer is dropping one of the assets it picked up in the takeover of Array Bio Pharma, worth 11.4 billion dollars three years ago. After carrying out a phase 3 interim futility analysis, Big Pharma has decided to stop working on the cardiovascular disease candidate PF-07265803. With Array BioPharma kicking it off in 2018, Pfizer […]

Continue Reading

WHO Director General Urged Pfizer to Make Oral Covid-19 Drug Available Widely

July 7, 2022July 7, 2022Sandy B

The Director-General of the UN World Health Organization (WHO), Tedros Adhanom Ghebreyesus, has called on Pfizer to do more to make sure that its new Covid-19 oral antiviral drug is available quickly to provide effective treatment to countries that might struggle to afford the medicine. This appeal comes as confirmed Covid-19 cases has increased by […]

Continue Reading

Pfizer to Provide Medicines at Manufacturing Costs to Poor Countries

May 26, 2022May 26, 2022Sandy B

On Wednesday, 25th May 2022, Pfizer said, riding high on the unprecedented success of the company’s corona virus that is going to be making 23 of its medicines and most of them have been patented and will be available for 45 of the low-income countries at the manufacturing price. Pfizer has now revealed the initiative, […]

Continue Reading

Pfizer to Purchase Biohaven Pharmaceuticals for $11.6 Billion

May 12, 2022May 12, 2022Sandy B

Pfizer Inc. said it is going to be purchasing the Biohaven Pharmaceutical Holding Co. for a sum of 11.6 billion dollars in cash for the purpose of gaining an approved treatment for the migraine headaches. Pfizer is also going to pay 148.50 dollars a share for all of the New Haven, which is a Connecticut-based […]

Continue Reading

Pfizer to Seek US Approval For 3rd Covid-19 Vaccine Shot in Children

April 21, 2022April 21, 2022Sandy B

Pfizer and BioNTech announced the positive results from the clinical trial that were conducted on the safety and immune response of a third dose of the novel corona virus vaccine in the children between the age of 5 to 11 years and the companies also added that, they are soon going to be seeking the […]

Continue Reading

Pfizer Agrees to Purchase ReViral Ltd. For Up To $525-Million

April 11, 2022April 11, 2022Sandy B

Pfizer Inc., has now agreed for purchasing the respiratory antiviral drug producing company ‘ReViral Ltd.’ For a sum of 525 million dollars as the latest move of the company in the one-time overlooked field of the infectious disease. The company ‘ReViral Ltd.’ Based in the United Kingdom has been developing the therapies for the respiratory […]

Continue Reading

Study: Pfizer Covid-19 Vaccine for 5-11 Years Old Cut Omicron Hospitalizations by 68%

April 4, 2022April 4, 2022Sandy B

As the corona virus vaccine developed by Pfizer and BioNTech have become available in October 2021 for the children coming in the age group of 5 to 11 years old, and most of the parents have been hesitant for having them vaccinated. On March 16 2022, only 27 percent had now received two corona virus […]

Continue Reading

Pfizer CEO, Company to Submit 4th Covid-19 Vaccine Shot to US FDA

March 9, 2022September 21, 2022Swati Jaiswal

Albert Bourla, chief executive officer of Pfizer said, the company is soon going to be submitting the data to the regulators of the United States on a fourth dose of the novel corona virus vaccine. He also said that, the new data from the different studies of the corona virus including the one focusing at […]

Continue Reading

Study: Efficacy of Pfizer, Moderna Vaccine Booster Wanes Significantly by Fourth Month

February 14, 2022February 14, 2022Sandy B

According to new study conducted by the Centers for Disease Control and Prevention (CDC) of the United States said that, the efficacy of the third doses or booster doses of the Pfizer and Moderna mRNA covid-19 vaccines wanes by the fourth month after the vaccination substantially. Although it has now been well documented that, the […]

Continue Reading

Posts navigation

Older posts

Latest News

  • Premier League Clubs Agree to Remove Gambling Sponsorships from Team Shirts

    April 14, 2023Sandy B
  • Russia’s Novatek to Gain Shell’s Stake in Sakhalin-2

    April 14, 2023Sandy B
  • Volkswagen Launches New-Gen Electric Motor to Power its “ID” Family

    April 14, 2023Sandy B
  • Egg Prices to Reach Record High in 2023 Globally

    April 13, 2023Sandy B
  • Audi Selects Ohme as Smart Charger Partner in UK

    April 13, 2023Sandy B
  • General Motors Invests EnergyX to Unlock Lithium Supply in North America

    April 13, 2023Sandy B
  • Top Fantasy Sports Companies in Europe in 2023

    April 12, 2023Sandy B
  • CDC Warns US Citizens of an Increasing STI Epidemic

    April 12, 2023Sandy B
  • BMW EV Sales Doubled in the US

    April 12, 2023Sandy B
  • Algeria Plan Clean Energy Projects to Supply Electricity to Europe

    April 12, 2023Sandy B

Categories

  • Agriculture (42)
  • Automobile (376)
  • Biotechnology (26)
  • Business (209)
  • Chemicals (72)
  • Consumer Goods (107)
  • Entertainment (18)
  • Environment (61)
  • Healthcare (245)
  • News (14)
  • Power & Energy (265)
  • Semiconductor (25)
  • Sports (50)
  • Technology (210)
  • Travel (29)
  • World (11)

About Us

The ‘industrywatch24’ is a digital news platform that delivers news for different types of industries. As the name suggests, we believe in delivering the latest news related to various industrial sectors 24×7. As a digital news website, we believe in delivering the right information, a person needs to know the current scenarios of the industries. 

Pages

  • About Us
  • Authors
  • Contact Us
  • Privacy Policy

Contact

IndustryWatch24
201, Skystation,
Viman Nagar, Pune ,
Maharashtra 411014,
India.
E-mail: [email protected]
Phone: +91 70 20 342 806
Copyright © 2022 IndustryWatch24 | Theme: News Portal by Mystery Themes.